High versus Low Blood-Pressure Target in Patients with Septic Shock
This multicentre, open label trial randomized over 700 patients with septic shock to undergo resuscitation to MAP target of 80-85 mmHg or 65-70 mmHg. The primary outcome of mortality was no different in either group at 28 or 90 days. However, the higher target group required less renal replacement therapy.
:
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care.
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
Source: Nephrology Now - Category: Urology & Nephrology Authors: Nephrology Now editors Tags: Acute Kidney Injury Clinical Nephrology Clinical Trial Results General Nephrology Source Type: research
More News: Cardiology | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Intensive Care | Septic Shock | Tekturna | Urology & Nephrology